Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response

References

• Pharmacists ASoH. AHFS drug information: published by authority of the Board of Directors of the American Society of Hospital Pharmacists; 2012.
   Google Scholar
• Guarneri V, Dieci MV, Conte P. Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Expert Opin Pharmacother. 2012;13:395–406.
   PubMed Web of Science ®Google Scholar
• Park JH, Yan YD, Chi SC, et al. Preparation and evaluation of Cremophor-free paclitaxel solid dispersion by a supercritical antisolvent process. J Pharm Pharmacol. 2011;63:491–499.
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 2009;133:11–17.
   PubMed Web of Science ®Google Scholar
• Fonseca C, Simoes S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release. 2002;83:273–286.
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Beg S, Mehta F, et al. Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. Expert Opin Drug Deliv. 2015;12:1809–1822.
   PubMed Web of Science ®Google Scholar
• Takegami S, Takara K, Tanaka S, et al. Characterization, in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions. J Microencapsul. 2010;27:453–459.
   PubMed Web of Science ®Google Scholar
• Shenoy VS, Rajyaguru TH, Gude RP, et al. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles. J Microencapsul. 2009;26:471–478.
   PubMed Web of Science ®Google Scholar
• Koudelka Š, Turánek J. Liposomal paclitaxel formulations. J Control Release. 2012;163:322–334.
   PubMed Web of Science ®Google Scholar
• Chiang P-C, Gould S, Nannini M, et al. Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity. Nanoscale Res Lett. 2014;9:1–10.
   PubMed Web of Science ®Google Scholar
• Lee SE, Bairstow SF, Werling JO, et al. Paclitaxel nanosuspensions for targeted chemotherapy–nanosuspension preparation, characterization, and use. Pharm Dev Technol. 2013;19:438–453.
   PubMed Web of Science ®Google Scholar
• Sim T, Lim C, Hoang NH, et al. Nanomedicines for oral administration based on diverse nanoplatform. J Pharm Investig. 2016;46:351–362.
   Google Scholar
• Arıca Yegin B, Benoît J-P, Lamprecht A. Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Dev Ind Pharm. 2006;32:1089–1094.
   PubMed Web of Science ®Google Scholar
• Wu L, Tang C, Yin C. Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly (ethylene glycol). Drug Dev Ind Pharm. 2010;36:439–448.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Kim JH, Choi JY, et al. pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy. J Mater Chem B. 2014;2:6324–6333.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li C, Shen C, et al. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Drug Deliv. 2016;23:2575–2580.
   PubMed Web of Science ®Google Scholar
• Pradhan R, Ramasamy T, Choi JY, et al. Hyaluronic acid-decorated poly (lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Carbohydr Polym. 2015;123:313–323.
   PubMed Web of Science ®Google Scholar
• Katragadda U, Fan W, Wang Y, et al. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis. PLoS One. 2013;8:e58619.
   PubMed Web of Science ®Google Scholar
• Choi JY, Thapa RK, Yong CS, et al. Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. J Pharm Investig. 2016;46:325–339.
   Google Scholar
• Tran TH, Nguyen HT, Pham TT, et al. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer. ACS Appl Mater Interfaces. 2015;7:28647–28655.
   PubMed Web of Science ®Google Scholar
• Chou T-C, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.
   PubMedGoogle Scholar
• Chou T-C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621–681.
   PubMed Web of Science ®Google Scholar
• Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. BioMed Res Int. 2012;2012:1–18. doi: 10.1155/2012/247597.
   Web of Science ®Google Scholar
• Tran TH, Nguyen TD, Poudel BK, et al. Development and evaluation of artesunate-loaded chitosan-coated lipid nanocapsule as a potential drug delivery system against breast cancer. AAPS PharmSciTech. 2015;16:1307–1316.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Tran TH, Kim JO, et al. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D, L-lactide-co-glycolide (PLGA) nanoparticles. Arch Pharm Res. 2015;38:716–724.
   PubMed Web of Science ®Google Scholar
• Ho HN, Tran TH, Tran TB, et al. Optimization and characterization of artesunate-loaded chitosan-decorated poly (D, L-lactide-co-glycolide) acid nanoparticles. J Nanomater. 2015;2015:1–12. doi: 10.1155/2015/674175.
   Web of Science ®Google Scholar
• Tran TH, Nguyen TD, Van Nguyen H, et al. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Arch Pharm Res. 2016;39:687–694.
   PubMed Web of Science ®Google Scholar
• Chadha R, Gupta S, Pathak N. Artesunate-loaded chitosan/lecithin nanoparticles: Preparation, characterization, and in vivo studies. Drug Dev Ind Pharm. 2012;38:1538–1546.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505–522.
   PubMed Web of Science ®Google Scholar
• Wang B, Yu X-C, Xu S-F, et al. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma. J Nanobiotechnol. 2015;13:1.
   PubMed Web of Science ®Google Scholar
• Roy A, Singh MS, Upadhyay P, et al. Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model. Int J Pharm. 2013;445:171–180.
   PubMed Web of Science ®Google Scholar
• Hamdy S, Molavi O, Ma Z, et al. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine. 2008;26:5046–5057.
   PubMed Web of Science ®Google Scholar
• Destache CJ, Belgum T, Christensen K, et al. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1. BMC Infect Dis. 2009;9:1.
   PubMed Web of Science ®Google Scholar
• Şengel-Türk CT, Hasçiçek C, Dogan AL, et al. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Dev Ind Pharm. 2012;38:1107–1116.
   PubMed Web of Science ®Google Scholar
• Chou TC, TaLaLay P. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors . Eur J Biochem. 1981;115:207–216.
   PubMedGoogle Scholar
• Liu K, Cang S, Ma Y, et al. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int. 2013;13:1.
   PubMed Web of Science ®Google Scholar
• Tran TH, Choi JY, Ramasamy T, et al. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr Polym. 2014;114:407–415.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Choi JY, Poudel BK, et al. Multilayer-coated liquid crystalline nanoparticles for effective sorafenib delivery to hepatocellular carcinoma. ACS Appl Mater Interfaces. 2015;7:20360–20368.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, et al. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995;184:39–51.
   PubMed Web of Science ®Google Scholar
• Zhou YZ, Alany RG, Chuang V, et al. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Dev Ind Pharm. 2013;39:321–330.
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials. 2000;21:2475–2490.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63:456–469.
   PubMed Web of Science ®Google Scholar
• Devi TR, Gayathri S. FTIR and FT-Raman spectral analysis of paclitaxel drugs. IJPSR. 2010;2:106–110.
   Google Scholar
• Augustijns P, D'hulst A, Van Daele J, et al. Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J Pharm Sci. 1996;85:577–579.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release. 2007;122:338–344.
   PubMed Web of Science ®Google Scholar
• Bittner B, Witt C, Mäder K, et al. Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. J Control Release. 1999;60:297–309.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: World Health Organization; 2006.
   Google Scholar
• Xiong S, Zhao X, Heng BC, et al. Cellular uptake of Poly‐(D, L‐lactide‐co‐glycolide)(PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method. Biotechnology J. 2011;6:501–508.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly (D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res. 2003;20:212–220.
   PubMed Web of Science ®Google Scholar